Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Harvard Business School
Baxter
Healthtrust
Teva
Boehringer Ingelheim
Dow
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Inpersol-zm W/ Dextrose 1.5% In Plastic Container, and what generic alternatives are available?

Inpersol-zm W/ Dextrose 1.5% In Plastic Container is a drug marketed by Fresenius Medcl and is included in one NDA.

The generic ingredient in INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER is calcium chloride; dextrose; sodium chloride; sodium lactate. There are two hundred and seventy-five drug master file entries for this compound. Additional details are available on the calcium chloride; dextrose; sodium chloride; sodium lactate profile page.
Summary for INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Drug patent expirations by year for INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Medcl INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 019395-001 Mar 26, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Teva
Daiichi Sankyo
UBS
Cerilliant
McKesson
Fuji
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.